General Information of the Compound
| Compound ID |
CP0048287
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Anilinoquinazoline, 4a
Show/Hide
|
||||||||||||||||||
| Synonyms |
153436-70-5
6-amino-4-(3'-methylanilino)quinazoline
6-amino-4-(3-methylphenylamino)-quinazoline
6-amino-4-[(3-methylphenyl)amino]quinazoline
6-amino-4[(3-methylphenyl)amino]quinazoline
AKOS013914431
Anilinoquinazoline, 4a
BDBM50133384
CHEMBL336113
FT-0765557
N*4*-m-Tolyl-quinazoline-4,6-diamine
N4-(3-methylphenyl)-4,6-quinazolinediamine
NFBCSWGEYDCCDW-UHFFFAOYSA-N
SCHEMBL159209
SMA-52
SMA52
ZINC6328
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H14N4
|
||||||||||||||||||
| Molecular Weight |
250.305
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(Nc2ncnc3ccc(N)cc23)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H14N4/c1-10-3-2-4-12(7-10)19-15-13-8-11(16)5-6-14(13)17-9-18-15/h2-9H,16H2,1H3,(H,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFBCSWGEYDCCDW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound